Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

American Family Physician June 1, 2006 Raghuveer Et Al.	Inborn Errors of Metabolism in Infancy and Early Childhood: An Update Primary care physicians often are the first to be contacted by state and reference laboratories when neonatal screening detects the possibility of an inborn error of metabolism. Physicians must take immediate steps to evaluate the infant and should be able to access a subspecialty center.
Managed Care June 2006 Thomas Morrow	Pompe Disease Therapy Presents Coverage Challenge Although Myozyme is approved for the infantile form of Pompe disease, it is logical to extend coverage to patients with the late onset form.
American Family Physician July 1, 2005 Wattendorf & Muenke	Diagnosis and Management of Fragile X Syndrome Fragile X syndrome is an X-linked inherited disorder. It is important to diagnose affected patients as early as possible to provide early intervention and supportive care and to inform parents for further family planning.
American Journal of Nursing August 2010 Lomas & Fowler	Parents and Children with Cystic Fibrosis A survey was conducted to estimate how many adult patients with cystic fibrosis who receive care at centers accredited by the Cystic Fibrosis Foundation also have biological children with the disease.
Nurse Practitioner September 2011 Cheryl L. Gainer	Celiac Disease: Helping Patients Live Gluten-Free A review of the screening, diagnosis, and treatment of celiac disease.
The Motley Fool June 3, 2004 Charly Travers	Small Drug Market, Big Hopes BioMarin is going to file for approval in the U.S. and Europe in the fourth quarter of this year after its succesful phase 3 trial of Aryplase. If the drug is approved, it would likely be on the market toward the end of 2005.
Pharmaceutical Executive April 10, 2014 Ben Comer	Sickle Cell Disease In Three Acts Is there a happy ending in store for sickle cell patients?
Chemistry World February 22, 2011 Amaya Camara-Campos	Repairing faulty genes Israeli scientists have developed compounds that could be better treatments for genetic diseases than current drugs.
Chemistry World July 3, 2014 Maria Burke	Renewed focus on dementia checked by drug challenges The risks and barriers for companies working in dementia are huge, but so too, potentially, are the rewards, says Simon Ridley, head of research at Alzheimer's Research UK.
Nursing November 2011 Lawson & Pruitt	Issues in Obesity, Part 2: Obesity Weighs Heavily on Lung Function A look at the impact of obesity on asthma, chronic obstructive pulmonary disease (COPD), and sleep apnea.
Nurse Practitioner August 2009 Linda A. Howe	Pharmacogenomics and management of cardiovascular disease Prior to the completion of the Human Genome Project in 2003, individual responses to medications were usually termed idiosyncrasies. Ethnic differences were not usually seen as genetic variants, as is the case today.
Pharmaceutical Executive November 1, 2011 Elizabeth O. Coulton	Clinical Trial Issues Not Just Black and White The selection of clinical trial participants must meld with the changing demographics of America if industry is to improve medicines that work for patients.
American Journal of Nursing October 2009	Pharmacogenomics: Personalizing Drug Therapy Pharmacogenomics is a rapidly growing field of research into the ways in which genetic variation affects drug response.
Nursing July 2011 Susan Simmons	Recognizing and Managing Rheumatoid Arthritis Here's what rheumatoid arthritis is, how it's diagnosed and treated, and what you can do to help patients manage the disease.
HHMI Bulletin Aug 2011	Seeing is Believing Today, researchers are finding clever ways to deliver long-lasting, healthy genes without triggering a serious immune response.
Fast Company Elizabeth Segran	23andMe And The FDA Reached A Pivotal Genetic Testing Agreement An FDA decision summary allows DNA-testing company 23andMe to market a genome test that screens for Bloom syndrome, a rare disorder that may lead toward the development of cancer.
Chemistry World February 25, 2015 Rebecca Trager	US opens up home DNA screening The US Food and Drug Administration has, for the first time, authorized a genetic test to be sold directly to consumers. The agency plans to ease the regulatory path for similar screening tests.
BusinessWeek April 22, 2010 Rob Waters	Gene Therapy Takes a Turn for the Better Researchers and investors are heartened by advances in gene therapy. Analysts say revenues are still several years off, however.
Pharmaceutical Executive December 1, 2011 Ben Comer	Pharm Exec's 2012 Pipeline Report It's a neck and neck race toward safer, faster, and medically superior treatments. Which organizations have what it takes to jockey their products into the winner's circle?
The Motley Fool January 26, 2005 John Bluis	Genzyme Feels the Heat Drug company faces first true competition to its enzyme replacement therapy for Gaucher disease.
Pharmaceutical Executive July 1, 2011 Dickmeyer & Rosenbeck	From Rut to Racetrack Can the pharmaceutical industry deliver on its objective to make cancer a curable, chronic condition?
Nurse Practitioner July 2011 Lori Mertz	Meningococcal Disease: Early Recognition is Vital to Patient Outcomes Education of healthcare professionals to improve identification and provide immediate treatment of patients with symptoms consistent with meningococcal disease will result in improved outcomes.
Managed Care November 2006 Thomas Morrow	Transgenic Drug Production Heads Back to the Farm The use of transgenic goats to produce a recombinant form of human antithrombin is much more efficient than using mammalian cell cultures.
HHMI Bulletin Nov 2010 Sarah C.P. Williams	Scientists Track Down Genetic Mutations In Record Time Scanning the human genome for a single disease-causing mutation is like taking a copy of War and Peace in a foreign language and searching for one misspelled word
IEEE Spectrum November 2007 Josh Romero	Three-Dimensional Medical Imaging Could Improve Doctors' Ability to Diagnose Fetal Alcohol Syndrome Laser scanners could help diagnose a birth defect that's difficult to detect.
Chemistry World July 2010 Anna Lewcock	Medicine made to measure Healthcare tailored to suit the genetic makeup of the patient is finally coming to fruition.
Nurse Practitioner November 2011 Tracy Brazziel et al.	Stopping the Wave of PAD Early detection and diagnosis of atherosclerotic disease is imperative. Here, learn the risk factors, screening and diagnosis for this disease.
Nurse Practitioner August 2011 Davis et al.	Supportive approaches for Alzheimer Disease Alzheimer disease accounts for almost 80% of all dementia diagnoses. Currently, more than 5 million Americans suffer from this debilitating illness, with the highest prevalence in the oldest age groups.
BusinessWeek September 1, 2009 Catherine Arnst	Opportunities in the Obesity Epidemic Drugmakers are ratcheting up research into treatments for gout and other ills that plague the overweight.
AskMen.com Jacob Franek	Future Cures Almost every disease known to man is under constant research and we can hardly go a day without hearing about some advancement or another. Here are a few diseases for which future cures could be looming on the horizon.
Scientific American June 2009 Melinda Wenner	Genetic Copy Variations and Disease A new sense for how variable numbers of genes cause disease.
Nursing September 2010 Margaret M. Bolton	Sounding the alarm about metabolic syndrome Any health problem that affects a third of American adults is sure to impact your nursing practice. Metabolic syndrome, a growing and commonly silent condition, poses a significant public health crisis.
HHMI Bulletin May 2012 Sarah C. P. Williams	Stephen Quake: Innovative Thinking on Genetic Tests His ideas have already led to a blood test to tell a pregnant woman whether her fetus has Down syndrome. Now, the HHMI investigator is pushing further, to track the success of heart transplants and diagnose autoimmune diseases and allergies.
Chemistry World November 5, 2012 Andrew Turley	Approval for first gene therapy drug Alipogene tiparvovec, marketed as Glybera, has become the first gene therapy drug to win approval in either the US or the EU.
The Motley Fool March 3, 2011 Ryan McBride	With Sanofi Buyout of Genzyme, Rare Disease Execs Upbeat About Interest in Their Niche The field might benefit from the increased interest in it among pharmaceutical players.
Chemistry World November 2010	Column: In the Pipeline Should drug companies focus on big markets and the blockbuster dream?
Pharmaceutical Executive December 1, 2010 Walter Armstrong	The Next Wave: Pharm Exec's 2011 Pipeline Report 42 of the best new drugs in development or parked at the FDA
Chemistry World July 2010 Hayley Birch	Special Report: Health breakthroughs of the decade New discoveries have been made with cancer vaccines, genomics, statin drugs, allosteric modulators, and RNA interference during the last decade.
The Motley Fool August 10, 2010 Ryan McBride	Vertex's Telaprevir Clears Hurdle, Could Halve Treatment Times for Hepatitis C Study results are positive.
IEEE Spectrum October 2011 Joseph M. Smith	Wireless Health Care Wireless technologies are about to transform health care, and not a moment too soon
Nurse Practitioner November 2009 Sandra M. Nettina	A New Look at Vitamin B12 Deficiency Many patients, especially the elderly, have risk factors for vitamin deficiency. A wellness visit is the ideal time to include vitamin B 12 education, especially for those with risk factors for developing deficiency.
American Family Physician September 15, 2001 David S. Smith	Health Care Management of Adults with Down Syndrome The family physician's holistic approach to patients forms the basis of good health care for adults with Down syndrome...
Popular Mechanics November 12, 2009 Bijal P. Trivedi	5 Animal Genomes That May Hold Cures to Human Diseases Having the genomic information will guide pharmaceutical assessments and new experimental gene therapies, many of which are being done in animals.
Information Today April 30, 2015	Nature Publishing Group Adds New Format to Its Journals Portfolio Nature Reviews Disease Primersonline will contain review articles called Primers that have overviews of diseases and disorders.
CIO October 29, 2015 Martha Heller	Amgen uses algorithms to venture into digital healthcare A senior vice president of global marketing and commercial development, says she's working with the CIO to set up a digital healthcare organization that can help physicians better predict how patients will respond to therapies.
The Motley Fool September 23, 2010 Brian Orelli	Ugly Side Effects Won't Derail This Drug Side effects don't matter much when there are no other treatment options, as in Cushing's disease.
Nursing March 2009 Kate J. Morse	Focusing on the Surgical Patient with Cardiac Problems Learn about the latest guidelines for assessing cardiac risk and protecting his heart during noncardiac surgery.
Chemistry World November 16, 2011 Helen Potter	Early diagnosis for Alzheimer's and Parkinson's US scientists have developed a biosensor that could detect the early stages of Alzheimer's disease and Parkinson's disease by measuring low concentrations of protein aggregates in cerebrospinal fluid.
American Family Physician August 15, 2000	Down Syndrome: What You Need to Know When You're Pregnant
Chemistry World December 7, 2011 Andrea McGhee	Artificial enzyme outperforms nature Scientists in China and the US have fabricated an artificial enzyme that may provide new hope for the treatment of Lou Gehrig's disease.